| 1 |
33468723 | [Effects of Olaparib, a PARP-1 Inhibitor, on Triple Negative Breast Cancer Cells with a BRCA1 Mutation]. | 2021 Jan |
1 |
| 2 |
33552258 | MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancreatic cancer cells. | 2021 Feb |
3 |
| 3 |
33975311 | The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety. | 2021 |
1 |
| 4 |
34201963 | Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. | 2021 Jun 25 |
1 |
| 5 |
31802375 | Combination of a novel microtubule inhibitor MBRI-001 and gemcitabine synergistically induces cell apoptosis by increasing DNA damage in pancreatic cancer cell lines. | 2020 Oct |
1 |
| 6 |
31989039 | CRISPR/Cas9-mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1-mutated breast cancer cells. | 2020 Jan |
1 |
| 7 |
30152517 | PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer. | 2019 Mar 1 |
2 |
| 8 |
31807190 | The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. | 2019 Dec |
2 |
| 9 |
28176879 | PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer. | 2017 Feb 8 |
2 |
| 10 |
28394191 | The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells. | 2017 Nov |
1 |
| 11 |
28770300 | Phase I study of veliparib in combination with gemcitabine. | 2017 Sep |
1 |
| 12 |
29048622 | Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. | 2017 Nov |
1 |
| 13 |
26677013 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells. | 2016 Mar |
2 |
| 14 |
27035235 | Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. | 2016 Jun |
1 |
| 15 |
25572120 | Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine. | 2015 Mar |
1 |
| 16 |
26028101 | In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways. | 2015 |
2 |
| 17 |
24607283 | PARP inhibitors in ovarian cancer: current status and future promise. | 2014 May |
1 |
| 18 |
25202071 | Decreased miR-206 expression in BRCA1 wild-type triple-negative breast cancer cells after concomitant treatment with gemcitabine and a Poly(ADP-ribose) polymerase-1 inhibitor. | 2014 Sep |
1 |
| 19 |
25271986 | Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. | 2014 |
2 |
| 20 |
23898224 | Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma. | 2013 |
2 |
| 21 |
23047891 | BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer. | 2012 Dec |
1 |
| 22 |
21368455 | [PARP inhibitors for cancer therapy]. | 2011 Jan |
1 |
| 23 |
21777194 | The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatment. | 2011 Dec |
1 |
| 24 |
20798217 | Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. | 2010 Oct 15 |
1 |
| 25 |
20940192 | Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. | 2010 Nov 20 |
2 |
| 26 |
20495713 | Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer. | 2009 Nov |
2 |
| 27 |
18572621 | Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. | 2008 Apr |
1 |
| 28 |
17444865 | Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells. | 2007 May |
1 |
| 29 |
16505115 | c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. | 2006 Feb |
1 |
| 30 |
15726400 | Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression. | 2005 Jun |
1 |